Institution statistics

FINOVATIS - France 

Ranking results:

Past rankings:
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:900-1000
Networking Rank (Reputation):700-800
Networking Rank (Reputation):700-800
2010
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
Ranking timeline:

European project participation (2010-01-01 - 2021-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 9
As coordinator: 0
As participant: 9
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2020 0 3.034.581 173.250 1
2017 0 5.697.391 320.938 1
2016 0 9.862.546 239.688 1
2015 0 6.338.259 232.000 1
2013 0 11.968.569 339.598 1
2012 0 20.995.870 1.322.995 3
2010 0 11.887.735 276.900 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
GATC BIOTECH4
UNIVERSITAET ZUERICH4
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS3
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE3
UNIVERSITY OF NEWCASTLE UPON TYNE3
ALACRIS THERANOSTICS2
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS2
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
EUROPAEISCHES INSTITUT FUER FORSCHUNG UND ENTWICKLUNG VON TRANSPLANTATIONSSTRATEGIEN2
GEORG SPEYER HAUS CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT2
UNIVERSITAETSKLINIKUM FREIBURG2
UNIVERSITE JOSEPH FOURIER GRENOBLE 12
UNIVERSITY COLLEGE LONDON2
ASSOCIATION GROUPE ESSEC1
ASSOCIATION INTERNATIONALE DE STANDARDISATION BIOLOGIQUE POUR L'EUROPE1
BIOGNOSYS1
BIOMAX INFORMATICS1
CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET MEDECINE1
CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE BESANCON1
CENTRE HOSPITALIER SAINTE ANNE DE PARIS1
CENTRE HOSPITALIER UNIVERSITAIRE DE GRENOBLE1
CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES1
CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE1
CERTUS TECHNOLOGY ASSOCIATES LIMITED1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
CHU COTE DE NACRE CAEN1
CHU HOPITAUX DE BORDEAUX1
CONSIGLIO NAZIONALE DELLE RICERCHE1
CR2O BV1
DEPARTMENT OF HEALTH GOVERNMENT OF WESTERN AUSTRALIA1
DEUTSCHES KREBSFORSCHUNGSZENTRUM1
ETABLISSEMENT FRANCAIS DU SANG1
EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION1
EUROPEAN MOLECULAR BIOLOGY LABORATORY1
EUROPEAN ORGANISATION FOR RARE DISEASES1
EUROPESE VERENIGING VOOR GEN EN CELTHERAPIE IVZW1
EVERCYTE1
FAKULTNI NEMOCNICE U SV ANNY V BRNE1
FINDACURE FOUNDATION1
FONDATION MALADIES RARES1
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR1
FONDAZIONE TELETHON1
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA1
FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE GIRONA DOCTOR JOSEP TRUETA1
FUNDACIO PRIVADA INSTITUT DE RECERCA DE L'HOSPITAL DE LA SANTA CREU I SANT PAU1
FUNDACIO PRIVADA PARC CIENTIFIC DE BARCELONA1
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III1
FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON1
GENETHON1
GENOSAFE SAS1
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT1
GUYS AND ST THOMAS' NHS FOUNDATIONTRUST1
HACETTEPE UNIVERSITESI1
HARBOUR ANTIBODIES BV1
HISTOCELL SL1
HLA ET MEDECINE1
HOSPICES CANTONAUX CHUV1
HOSPICES CIVILS DE LYON1
INNOLYST INC CORPORATION PATIENTCROSSROADS1
INSTITUTO DE SALUD CARLOS III1
INTERACTIVE BIOSOFTWARE SARL1
ISTITUTO ORTOPEDICO RIZZOLI1
ISTITUTO SUPERIORE DI SANITA1
ITASUOMEN YLIOPISTO1
KAROLINSKA INSTITUTE1
KLINIKUM DER JOHANN WOLFGANG GOETHE UNIVERSITAET1
KLINIKUM DER UNIVERSITAET ZU KOELN1
LEIBNIZINSTITUT FUR ALTERNSFORSCHUNG FRITZLIPMANNINSTITUT EV LEIBNIZ INSTITUTE ON AGING FRITZ LIPMANN INSTITUTE EV1
LEIDEN UNIVERSITY MEDICAL CENTER1
MEDIZINISCHE HOCHSCHULE HANNOVER1
MEDIZINISCHE UNIVERSITAT GRAZ MEDUNI GRAZ1
MILTENYI BIOTEC1
MOLECULAR MEDICINE1
MURDOCH CHILDRENS RESEARCH INSTITUTE1
MURDOCH UNIVERSITY1
NOVADISCOVERY1
NOVADISCOVERY SAS1
OSPEDALE PEDIATRICO BAMBINO GESU1
OY MEDFILES1
PIRKANMAA HOSPITAL DISTRICT1
POLYGENE1
PRIMM1
SCIOMICS1
SERVICIO ANDALUZ DE SALUD1
SERVICIO DE SALUD DE CASTILLA LA MANCHA1
SERVICIO MADRILENO DE SALUD1
SERVIZO GALEGO DE SAUDE1
SIMULA RESEARCH LABORATORY AS1
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS1
STIFTUNG TIERAERZTLICHE HOCHSCHULE HANNOVER1
TAMPEREEN KORKEAKOULUSAATIO SR1
TECHNISCHE UNIVERSITAET DRESDEN1
THE UNIVERSITY OF MANCHESTER1
UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES1
UNIVERSIDADE DE AVEIRO1
UNIVERSITA DEGLI STUDI DELL'AQUILA1
UNIVERSITA DEGLI STUDI DI PAVIA1
UNIVERSITA VITA SALUTE SAN RAFFAELE1
UNIVERSITAET ULM1
UNIVERSITAETSKLINIKUM HAMBURGEPPENDORF1
Constancy:

Total number of partners:134

Partner loyalty:
Frequent Partner: (> 2 projects): 17
Rare Partner: 117

Frequent / Rare Partner Ratio: 0.15

Diversity:

Categories:
Category:No:
RTD HORIZONTAL TOPICS3
BIOLOGICAL SCIENCES2

Project overview:

Start dateProjectacronymrolefundingpartners
2020-03-01Monoclonal Antibodies against 2019-New Coronavirus MANCOparticipant3.034.5818
2017-12-01Repurposing of carbamazepine for treatment of skeletal dysplasia MCDS-Therapyparticipant5.697.39110
2016-03-01Generation of the CanPath prototype - a platform for predictive cancer pathway modeling CanPathProparticipant9.862.5469
2015-09-01REgenerative Stem cell therapy for STroke in Europe RESSTOREparticipant6.338.25931
2013-10-01Systems biology for the functional validation of genetic determinants of skeletal diseases SYBILparticipant11.968.56918
2012-12-01Gene Therapy for X-linked Chronic Granulomatous Disease (CGD) NET4CGDparticipant5.999.60711
2012-11-01"RD-CONNECT: An integrated platform connecting registries, biobanks and clinical bioinformatics for rare disease research" RD-CONNECTparticipant11.997.11127
2012-11-01Systems prediction of Chronic Lung Allograft Dysfunction SYSCLADparticipant2.999.1529
2010-11-01Advanced Cell-based Therapies for the treatment of Primary ImmunoDeficiency CELL-PIDparticipant11.887.73520

Alias institution names:
  • FINOVATIS

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum